Related Experiment Video
Updated: Jan 31, 2026

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation
Published on: January 7, 2019
Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
Matilda Lee1, Jayshree L Hirpara2, Jie-Qing Eu2
1Department of Haematology-Oncology, National University Health System, Singapore; Haematology-Oncology Research Group, National University Cancer Institute of Singapore, National University Health System, Singapore.
Targeting signal transducer and activator of transcription 3 (STAT3) and oxidative phosphorylation (OXPHOS) offers new hope for overcoming drug resistance in oncogene-addicted cancers. Strategies focus on restoring sensitivity by inhibiting these key pathways.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Drug resistance in oncogene-addicted cancers limits targeted therapy effectiveness.
- Upregulation of signal transducer and activator of transcription 3 (STAT3) is a known resistance mechanism.
- Emerging evidence links metabolic reprogramming, specifically oxidative phosphorylation (OXPHOS), to cancer cell survival and drug resistance.
Purpose of the Study:
- To review the roles of STAT3 and OXPHOS in cancer drug resistance.
- To explore novel therapeutic strategies targeting STAT3 and OXPHOS.
- To discuss the potential for restoring drug sensitivity in resistant tumors.
Main Methods:
- Literature review of STAT3 signaling and cancer metabolism.
- Analysis of therapeutic strategies targeting STAT3 and OXPHOS.
- Discussion of challenges and future directions in drug development.
Main Results:
- STAT3's mitochondrial localization may link signaling pathways to cancer metabolism.
- Repurposed drugs (metformin, phenformin) and novel compounds show anti-cancer activity by inhibiting OXPHOS.
- STAT3 inhibitors face challenges with delivery, specificity, and toxicity.
Conclusions:
- Targeting STAT3 and OXPHOS represents a promising therapeutic avenue for overcoming drug resistance.
- Further research is needed to develop compounds with favorable toxicity profiles and robust biomarkers.
- Transforming cancer cell metabolism offers a new frontier in cancer treatment.
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Oxidation Numbers
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Drug Abuse and Addiction: Pharmacological Phenomena
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Oxidation-Reduction Reactions

